Show simple item record

dc.contributor.authorRussell, Hen_US
dc.contributor.authorPranjol, MZIen_US
dc.date.accessioned2019-09-26T11:29:19Z
dc.date.issued2018-01-01en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/59864
dc.descriptionThis article has been accepted for publication in Bioscience Horizons. Published by Oxford University Press.en_US
dc.description.abstract© The Author(s) 2018. Transcription factors (TFs), such as Snail, Slug and Twist, control the down-regulation of cell-cell adhesion molecule Ecadherin in ovarian cancer. Low E-cadherin aids tumour cells in undergoing epithelial-mesenchymal transition (EMT) to motile morphology, disseminating to other organs. High TF levels have also correlated with chemoresistance and poor prognosis. This review aims to discern mechanisms of E-cadherin reduction by TFs and identifies hypoxia-inducible factor 1α (HIF1α) as an upstream regulator in hypoxic conditions. Association with chemoresistance is investigated, and whether its reversal is possible. Snail was found to bind more strongly to the E-cadherin promoter than Slug; it was suggested that Snail maintained EMT whilst Slug induced it. The use of differential zinc fingers by Snail and Slug to bind to the E-cadherin promoter supported this. HIF1α was shown to lie upstream of all three TFs and protein degradation or post-transcriptional regulation using miR-548c may regulate of Twist downstream. Further study into this is needed. High Snail expression correlated with cisplatin resistance, with knockdown of Snail reversing it. The same may be true for Twist and Slug, though some studies conflicted this. These findings show promising potential of TFs and HIF1α as therapeutic targets for EMT prevention and even chemoresistance reversal.en_US
dc.language.isoenen_US
dc.relation.ispartofBioscience Horizonsen_US
dc.rightsCreative Commons Attribution
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleTranscription factors controlling E-cadherin downregulation in ovarian canceren_US
dc.typeArticle
dc.rights.holderThe Author(s) 2018. Published by Oxford University Press.
dc.identifier.doi10.1093/biohorizons/hzy010en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume11en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution
Except where otherwise noted, this item's license is described as Creative Commons Attribution